HISTOGENEX
HistoGeneX Laboratories is a privately held service provider of biomarker technologies for translational and clinical research and is a CAP, CLIA and BELAC-accredited laboratory. With facilities located in Antwerp, Belgium and Chicago, Illinois, and taking steps to establish a site in China, HistoGeneX provides a networked footprint for global clinical trials. Our services and products stem from a pathology and patient care perspective. We are experts at handling all human biological specimens and deploy the relevant technologies to extract the valuable information contained within for research and diagnostic applications.
HISTOGENEX
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2001-01-01
Address:
Antwerp, Antwerpen, Belgium
Country:
Belgium
Website Url:
http://www.histogenex.com
Total Employee:
101+
Status:
Active
Contact:
+32 3 218 10 80
Total Funding:
0
Technology used in webpage:
SPF Apple Mobile Web Clips Icon Domain Not Resolving Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail ReCAPTCHA Sectigo SSL ReCAPTCHA V2 Sectigo Domain SSL
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Current Employees Featured
Founder
Investors List
Waterland Private Equity
Waterland Private Equity investment in Private Equity Round - HistoGeneX
Official Site Inspections
http://www.histogenex.com
- Host name: hosting13.parkour3.com
- IP address: 159.89.115.187
- Location: Toronto Canada
- Latitude: 43.6547
- Longitude: -79.3623
- Timezone: America/Toronto
- Postal: M5A
More informations about "HistoGeneX"
Caprion-HistoGeneX Unites as CellCarta- Precision …
January 26, 2021. Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta. MONTREAL, Canada, January 26, 2021 – Caprion-HistoGeneX, a leading global provider of specialized precision medicine laboratory services …See details»
About us - CellCarta
Mr. Ung leads the development and execution of HistoGeneX’s strategic and business initiatives, leveraging the company’s solid tumor and anatomic pathology services. Prior to joining …See details»
HistoGeneX - Crunchbase Company Profile & Funding
HistoGeneX Laboratories is a privately held service provider of biomarker technologies for translational and clinical research and is a CAP, CLIA and BELAC-accredited laboratory. With facilities located in Antwerp, Belgium and …See details»
Caprion Becomes CellCarta: CRO Rebrands After …
Feb 1, 2021 Montreal, Canada-based Caprion Biosciences announced last week that the clinical research organization (CRO) will rebrand as CellCarta.The move follows the 2019 merger between Caprion and HistoGeneX, a Belgian …See details»
Precision Medicine Leader Caprion-HistoGeneX …
MONTREAL, Jan. 26, 2021 /PRNewswire/ - Caprion-HistoGeneX, a leading global provider of specialized precision medicine laboratory services to the biopharmaceutical industry, is pleased to announce ...See details»
CellCarta Company Profile - Craft
CellCarta (formerly known as Caprion-HistoGeneX) is a contract research organization (CRO) with expertise in immune monitoring, proteomics, and biomarker research. It offers testing …See details»
CellCarta Company Profile - Office Locations, Competitors ... - Craft
CellCarta (formerly known as HistoGeneX) is a service provider of biomarker technologies for translational and clinical research and is a CAP, CLIA, and BELAC-accredited laboratory. It …See details»
Caprion-HistoGeneX Rebrands As CellCarta | Contract Pharma
Jan 26, 2021 Caprion-HistoGeneX, a Montreal-based global provider of specialized precision medicine lab services, has rebranded as CellCarta.The company's mission is mapping the …See details»
Histogenex Company Profile 2024: Valuation, Investors ... - PitchBook
Histogenex General Information Description. Provider of laboratory services for immune-oncology therapies. The company supports pharmaceutical and biotechnology companies in the …See details»
Caprion and HistoGeneX Merge to Lead Global Immune …
Jul 31, 2019 Caprion Biosciences and HistoGeneX Unite Businesses to Create Global Leader in Immune Monitoring and Biomarker Development. Partnership Facilitated by Major Investment …See details»
Caprion Biosciences and HistoGeneX Unite Businesses to
Jul 31, 2019 Partnership Facilitated by Major Investment from Arsenal Capital Partners. NEW YORK, July 31, 2019 /CNW/ -- Caprion Biosciences ("Caprion") and HistoGeneX announced …See details»
HistoGeneX - Contacts, Employees, Board Members, Advisors
HistoGeneX is provider of biomarker technologies for translational and clinical research and is a CAP, CLIA and BELAC-accredited laboratory. ... Products. Resources. Pricing. Resources. …See details»
Caprion Biosciences and HistoGeneX Unite Businesses to Create …
Aug 9, 2019 Partnership Facilitated by Major Investment from Arsenal Capital Partners. NEW YORK /PRNewswire/ -- Caprion Biosciences ("Caprion") and HistoGeneX announced today …See details»
HistoGeneX - Products, Competitors, Financials, Employees, …
HistoGeneX supports pharmaceutical and biotechnology companies in the process of developing, approving and monitoring new cancer drugs by developing and carrying out biomarker tests. …See details»
HistoGeneX - VentureRadar
HistoGeneX is involved since 2003 in several oncology trials and is responsible for tissue biomarker development, validation and GLP/GCP testing/cancer profiling. * TAGS : Life …See details»
We Expand Histological Biomarker Analysis with Mosaic Laboratories
Jan 12, 2021 Caprion-HistoGeneX is a leading provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Leveraging its integrated analytical …See details»
HistoGeneX - Company Profile - BizStanding
Company Profile. Industry: Biotechnology Site: histogenex.com Description: AT HISTOGENEX, WE TAKE PRIDE IN BRIDGING TECHNOLOGIES, EXPERTISE AND EXPERIENCE. Our …See details»
☑️HistoGeneX NV — Consulting Organization from
HistoGeneX NV — Consulting Organization from Belgium, has experience with Horizon 2020 (2014 - 2020), Horizon Europe (2021 - 2027), it`s involved in Health, Research sectors.See details»
CellCarta Pathology Team with Expertise in Digital Pathology
Dr. Mark Kockx founded HistoGeneX Laboratories in 2001. At the University of Antwerp, Belgium, Dr. Kockx pioneered methodologies to elucidate apoptotic and cytostatic responses of cancer …See details»